PHILADELPHIA — The Philadelphia Eagles will be without their franchise quarterback this Sunday against the Carolina Panthers as Jalen Hurts grapples with a concerning medical diagnosis. The team officially announced on Thursday that the star signal-caller has been ruled out for Week 6 due to a superficial blood clot.
The situation stems from an incident during the team’s game against the Los Angeles Rams earlier this month. According to the Eagles’ medical staff, Hurts sought treatment for a calf injury on October 8 after being cleated during the contest. When the team arrived in London for their subsequent matchup, an ultrasound performed on October 10 revealed a superficial blood clot.
At that time, team doctors and medical specialists determined that the clot did not pose an immediate danger, concluding that “activity and mobility were important and that Jalen could safely play.” Following that medical guidance, Hurts remained on the field, competing “without limitation” against the Jacksonville Jaguars last week. He even participated in a full practice session on Wednesday after undergoing routine treatment earlier in the week.
However, the outlook changed following a follow-up ultrasound conducted on Wednesday. That scan revealed “movement in the small blood clot,” forcing the organization to hit the brakes on the quarterback’s return to the field.
“The health and safety of our players is our primary concern,” the team said in a statement. The Eagles confirmed they are currently in close communication with the NFL to determine the “appropriate course of treatment” for Hurts. As of Thursday, there is no definitive timeline for his return, and it remains unclear if he will be sidelined beyond this Sunday’s game against Carolina.
The unexpected absence leaves a significant void in the Eagles’ offense. In Hurts’ stead, the team will turn to backup Tanner McKee. McKee, who was drafted by the Eagles in 2023, has limited professional experience, having appeared in only six career NFL games. He will be tasked with leading the Philadelphia offense as the team attempts to maintain momentum in a highly competitive NFC landscape.
The news has sent ripples through the league, as blood clot issues have historically been treated with extreme caution in professional athletics. While the Eagles maintained that the clot was initially deemed manageable, the development of movement within the vein represents a significant escalation that necessitates a more conservative approach.
As the Eagles prepare for the Panthers, the focus remains on stabilization and further evaluation. For now, the team’s championship aspirations temporarily rest in the hands of the young backup, with the entire organization waiting for further clarity on their MVP candidate’s status.
Disclaimer: This content is auto-generated for informational purposes only.
Source: Read Original News
